维普期刊资源整合服务平台（V6.5）

57篇 您的检索式：作者名="Willman CL"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia : a Southwest Oncology Group study 显示文摘	List AF Kopecky KJ Willman CL	2001	Blood2001，98，12：	1
2	Langerhans cell histiocytosis (histiocy- tosis X): irnmunopheno-type and growth fraction显示文摘	Hage C Willman CL Favara BE	1993	Hum Pathol1993，24，8：	1
3	Langerhans' cell histiocytosis (histiocytosis X)-a clonal proliferative diseas 显示文摘	Willman CL Busque L Griffith BB	1994	N Engl J Med1994，331，3：	1
4	Benefit of cyclosporine modulation of drug resistance in atpients with poor-risk acute myeloid leukemia:a Southwest Oncology Group Study显示文摘	List AF Kopecky KJ Willman CL	2001	Blood2001，98，：	1
5	Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin:a Southwest Oncology Group Study显示文摘	Anderson JE Kopechy KJ Willman Cl	2002	Blood2002，100，12：	1
6	Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses 显示文摘	Li HY Appelbaum FR Willman CL	2003	Blood2003，101，9：	1
7	Benefit of cyclosporine modulation of drug resistance in patient with poor-risk acute myeloid leukemia:a South-west Oneology Group study显示文摘	Kopecky KJ Willman CL	2001	Blood2001，98，12：	1
8	Langerhans'-cell histiocytosis ( histiocytosis X)-a clonal proliferative disease 显示文摘	Willman CL Busque L Griffith BB	1994	N Engl J Med1994，331，3：	1
9	Langerhans'-cell histiocytosis ( histiocytosis X) : a clonal proliferative disaese 显示文摘	Willman CL Busque L Gritlith B B	1994	N Engl J Med1994，331，3：	1
10	Langerhans'cell histiocytosis (histioeytosis X)--a elonal proliferative disease显示文摘	Willman CL Busque L Griffith BB	1994	N Engl J Med1994，331，3：	1
11	Cholesterolmodulatinf agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses 显示文摘	Li HY Appelbaum FR Willman CL	2003	Blood2003，101，9：	1
12	Langerhans cell histiocytosis( histiocytosis X )-a clonal proliferative disease显示文摘	Willman CL Busque L Griffith BB	1994	N Engl J Med1994，331，：	1
13	Langerhans'-cell histio- cytosis ( histiocytosis X) - a elonal proliferative disease显示文摘	Willman CL Busque L Griffith BB	1994	N EnglJ Med1994，331，3：	1
14	Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia:a Southwest Oncology Group/Eastern Cooperative Oncology Group Study显示文摘	Slovak ML Kopecky K J Cassileth PA Harrington DH Theil KS Mohamed A Paietta E Willman CL Head DR Rowe JM Forman SJ Appelbaum FR	2000	Blood2000，96，13：	1
15	Molecular analysis and clinical outcomeof adult APL patients with the type V PML-RARa isoform: results from Intergroup protocol0129显示文摘	Slack JL Willman CL Andersen JW	2000	Blood2000，95，：	1
16	Benefit of cyclospo- fine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oneology Group study显示文摘	List AF Kopeeky KJ Willman CL	2001	Blood2001，98，12：	1
17	Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease显示文摘	Willman CL Busque L Griffith BB	1994	N Engl J Med1994，331，：	1
18	Langerhans cell histiocytosis (histiocytosis X):a clonal proliferative disease显示文摘	Willman CL Brusque L Griffith BB	1994	N Engl J Med1994，331，1：	1
19	Biologic parameters that predict treatment response in de novo acute myeloid leuken ia;CD34 but not MDR gene expression si associated with a decerased complete remission(CR) rate and CD+34 patients moer frequently achieve CRwith high dose cytosine arabinoside显示文摘	Willman CL Kopecky KL Weick J	1992	Proc ASCO1992，11，：	1
20	Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)显示文摘	Garrido SM Appelbaum FR Willman CL	2001	Exp Hematol2001，29，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示